Skip to content
Save up to 80%

Mysoline

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Select pack Package Per unit Price

Free delivery on orders from R 3 930.00, free express delivery from R 5 895.00

Secure Payments
Track your order
Best price guarantee

Mysoline is a primidone-based prescription medicine for people with selected seizures or essential tremor. Its active ingredient and metabolites help calm excessive electrical activity in the brain and support neurological symptom control.

Description

Mysoline is a prescription anticonvulsant containing primidone for certain epileptic seizures and essential tremor. It reduces excessive electrical activity in the brain through primidone and active metabolites, including phenobarbital. The tablets are taken on a regular schedule selected for the individual patient.

Composition

Mysoline contains primidone, an anticonvulsant related to the barbiturate family. Primidone is used in neurology to reduce abnormal neuronal firing associated with seizures and, in selected patients, essential tremor. The product is supplied as tablets.

Primidone belongs to the antiepileptic and anticonvulsant drug groups. Its clinical effects arise from the parent compound and active metabolites formed after absorption. Mysoline is therefore managed as a central nervous system medicine rather than as a simple symptom-relief product.

Active Ingredient and Formulation

The active ingredient is primidone. The tablet form supports regular oral dosing, which helps maintain steadier exposure than occasional use.

The strength and daily schedule are selected by the prescriber. Treatment often begins cautiously because dizziness, sleepiness, nausea, or poor coordination may appear when the nervous system is adjusting.

Primidone treatment is usually introduced gradually. A sudden increase can make drowsiness and unsteadiness much more noticeable during the first days.

Dosage and usage

Mysoline tablets are taken by mouth according to the prescribed schedule. The exact dose depends on the indication, previous anticonvulsant exposure, age, kidney and liver function, and response.

Typical clinical administration follows these principles:

  • Treatment is started at a low dose and increased gradually.
  • The daily amount may be divided into two or more doses.
  • Doses should be taken at consistent times.
  • Tablets should be swallowed with water unless a prescriber gives different administration instructions.
  • A missed dose should be taken when remembered unless the next scheduled dose is near.
  • Two doses should not be taken together to compensate for a missed dose.
  • Treatment should not be stopped suddenly.

Food may reduce stomach discomfort for some people. Alcohol can intensify sleepiness, poor coordination, and slowed breathing, so combining the two creates a clinically relevant risk.

One practical issue is timing. If a dose causes marked daytime sedation, the prescribing clinician may adjust the schedule, but the patient should not redesign the regimen independently. Seizure control can deteriorate when doses are shifted repeatedly.

How it works

After oral absorption, primidone is processed in the liver and converted partly into phenobarbital and phenylethylmalonamide, also called PEMA. These metabolites contribute to the medicine’s anticonvulsant activity.

Phenobarbital enhances inhibitory signalling in the central nervous system, helping nerve cells resist repetitive, uncontrolled firing. Primidone itself also contributes to seizure control. Together, these effects lower neuronal excitability.

The same central nervous system activity explains common treatment problems. Sleepiness, slowed reaction time, dizziness, and impaired balance may become more pronounced after a dose increase or when alcohol or another sedative is added.

Do not drive, cycle in traffic, or operate machinery until the individual effect is clear. The first few treatment days can feel more sedating than later weeks.

The United States Food and Drug Administration describes gradual dose reduction when discontinuation is required [1].

Indications

Mysoline is prescribed for certain forms of epilepsy, including generalized tonic-clonic seizures and complex partial seizures. It may also be used for essential tremor, a neurological condition that commonly causes rhythmic shaking of the hands during posture or movement.

Clinical use Main treatment goal Clinical context
Generalized tonic-clonic seizures Reduce seizure frequency Long-term seizure control
Complex partial seizures Limit focal seizure activity May be used alone or with another anticonvulsant
Essential tremor Reduce action tremor Use depends on symptom severity and treatment response

The American Academy of Neurology has identified primidone as an established treatment option for essential tremor. Its use for epilepsy follows the patient’s seizure type, previous treatment history, age, organ function, and interaction profile.

A person who has not used an anticonvulsant before may need a slower introduction than someone transitioning from another established regimen. The dose is not selected from body weight alone; neurological response and tolerability also guide adjustments.

Comparison

Mysoline is selected according to seizure type, tremor pattern, comorbidities, and interactions. The table compares treatment approaches by pharmacology rather than by commercial brand.

Treatment approach Main pharmacological feature Typical clinical consideration
Primidone Produces primidone effects and active barbiturate-related metabolites Useful for selected epilepsy syndromes and essential tremor
Sodium-channel-focused anticonvulsants Reduce repetitive neuronal firing through voltage-gated sodium channels Choice depends on seizure type and patient factors
GABA-enhancing anticonvulsants Strengthen inhibitory signalling in the brain Sedation and interaction burden vary between medicines

For essential tremor, primidone is often considered when symptoms interfere with writing, eating, work, or other daily tasks. The benefit must be balanced against early dizziness, fatigue, nausea, and impaired coordination.

For epilepsy, the correct comparison is not simply “stronger” or “weaker” treatment. A medicine can be suitable for one seizure pattern and unsuitable for another. NICE guidance stresses matching anticonvulsant therapy to seizure type and reviewing treatment when seizures continue or adverse effects become troublesome [2].

Contraindications

This medication is not for you if you have a known serious allergy to primidone, phenobarbital, or a related barbiturate. It is also unsuitable in acute intermittent porphyria because barbiturate-related medicines can worsen porphyrin production.

Mysoline requires particular caution or specialist review in the following situations:

  • Severe respiratory insufficiency.
  • Severe liver disease.
  • Significant kidney impairment.
  • A history of depression, suicidal thinking, or major mood instability.
  • Pregnancy, planned pregnancy, or breastfeeding.
  • Previous severe reaction to an anticonvulsant.
  • Use of several medicines that cause sedation.
  • A job or daily activity requiring rapid reactions and precise balance.

When this is not for you

Avoid Mysoline if you have had a serious allergic reaction to primidone, phenobarbital, or similar barbiturate medicines, or if you have acute intermittent porphyria. Tell your clinician before treatment if you have serious breathing, liver, or kidney problems, a history of severe mood symptoms, are pregnant or breastfeeding, or take several medicines that make you sleepy.

You should also discuss Mysoline carefully if your work or daily activities require fast reactions and steady balance. Hormonal contraception may become less reliable, so people using pills, implants, patches, or other hormone-based methods need an individual contraceptive plan.

Side effects

The most common early effects are drowsiness, dizziness, nausea, vomiting, reduced coordination, blurred vision, and fatigue. These effects may lessen after the body adapts, especially when the dose is increased slowly.

Longer-term problems can include persistent sedation, mood changes, reduced concentration, sexual dysfunction, and changes in blood counts. Some patients describe a “heavy” feeling in the morning rather than a single dramatic symptom.

Seek urgent medical attention for breathing difficulty, severe rash, facial swelling, fainting, profound confusion, suicidal thoughts, or a marked deterioration in seizure control. A serious allergic reaction can begin with rash and progress rapidly.

A medicine diary can reveal whether dizziness appears soon after each dose or persists throughout the day. That pattern gives the prescriber useful information for adjusting timing or dose.

People often underestimate the effect on balance. Stairs, showers, and uneven ground can become hazardous when primidone causes ataxia, especially after a dose increase.

Blood tests may be required during longer treatment. A clinician may monitor blood count, liver function, kidney function, and drug concentrations when symptoms, interactions, pregnancy, or seizure instability create a reason for testing.

Common mistakes

  • Stopping Mysoline after several symptom-free weeks.
  • Increasing the dose without a planned titration schedule.
  • Taking an extra tablet after a missed dose.
  • Drinking alcohol while assessing the medicine’s sedating effect.
  • Forgetting to mention hormonal contraception or cancer treatment.
  • Driving before dizziness and reaction-time changes have settled.
  • Assuming a different tablet appearance means the medicine is incorrect.
  • Treating a new rash as a minor irritation.
  • Failing to report mood changes or unusual thoughts.
  • Taking another sedative at night without considering additive effects.

What doctors say

In clinical practice, neurologists usually set modest early expectations. Primidone may reduce seizure frequency or tremor severity, but the response is individual and may take several dose adjustments.

For essential tremor, a doctor will often ask which activities are affected. Difficulty holding a cup, signing a document, using cutlery, or performing skilled work gives a clearer treatment target than a general statement that the hands “shake.”

Doctors also assess function, not only symptom reduction. A smaller tremor is not a good trade if the person cannot stay awake, walk steadily, or think clearly during the day.

A useful clinical review includes seizure or tremor frequency, dose timing, falls, driving status, sleep quality, mood, alcohol intake, and every prescription or non-prescription medicine. Phenobarbital concentrations may remain relevant even when the patient feels the primidone dose itself is modest.

Frequently asked questions

What is Mysoline used for?

Mysoline is used for selected epileptic seizures and essential tremor. NICE guidance published in 2022 supports treatment selection according to seizure type, while the American Academy of Neurology recognises primidone as an option for essential tremor. The medicine should be matched to the neurological diagnosis rather than used for unexplained shaking or episodes without assessment.

How does primidone work?

Primidone acts in the central nervous system and is converted partly into phenobarbital and PEMA. The resulting inhibitory effects reduce excessive neuronal activity. The FDA prescribing information published in 2016 describes primidone’s anticonvulsant activity and the importance of gradual dose changes .

Can Mysoline be stopped suddenly?

Abrupt discontinuation can increase seizure risk and may produce withdrawal-related symptoms. The dose is normally reduced gradually under clinical supervision. NICE guidance from 2022 supports structured medication review when treatment is changed, especially in people with ongoing seizure risk.

Does Mysoline affect contraception?

Primidone can increase the breakdown of contraceptive hormones, which may reduce the reliability of some hormonal methods. The World Health Organization’s Medical Eligibility Criteria, updated in 2015, treats enzyme-inducing anticonvulsants as relevant when selecting contraception. A non-hormonal or specially planned method may be needed.

Can Mysoline be used during pregnancy?

Pregnancy decisions require a balance between seizure control and medicine-related fetal risk. The European Medicines Agency published pregnancy-safety information for antiseizure medicines in 2019, and treatment planning should begin before conception where possible. Stopping therapy without a replacement plan can create serious seizure risk.

Why does Mysoline cause sleepiness?

The FDA prescribing information from 2016 explains that primidone and phenobarbital reduce excessive brain activity, and that effect can also slow alertness and coordination. Sedation is often strongest after initiation or dose increases. Alcohol, opioids, sleeping tablets, and sedating antihistamines can intensify it.

What should happen after a missed dose?

Take the missed tablet when remembered unless the next dose is close. Skipping the missed dose is safer than taking two doses together. The FDA-approved prescribing information and clinical practice guidance available in 2022 support avoiding abrupt changes that could destabilise seizure control .

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Mysoline: Reviews and Experiences

4
Based on 4 reviews
Sarah, 42 Cape Town 6 weeks
Verified
Rating: 4 out of 5

The first week on the prescribed starting dose brought dizziness and a sleepy feeling. After gradual adjustments over several weeks, handwriting became easier, although the morning tiredness never disappeared completely.

06 Nov 2026
Thabo, 38 Durban 3 months
Verified
Rating: 5 out of 5

Mysoline helped reduce breakthrough seizures after the regimen was adjusted. I still needed regular appointments because missing one evening dose was followed by a warning aura the next day.

12 Nov 2026
Michael, 51 Johannesburg 2 months
Verified
Rating: 3.5 out of 5

The shaking improved, but I stopped taking it for several days because I disliked feeling slow at work. The clinician changed the timing and increased it more carefully afterward.

16 Oct 2026
Emily, 34 Gqeberha 4 weeks
Verified
Rating: 3.5 out of 5

My contraceptive plan had to be reviewed after starting primidone. I had not realised enzyme-inducing anticonvulsants could affect hormonal contraception.

26 Oct 2026

Sources

  1. U.S. Food and Drug Administration (2016). Mysoline (primidone) tablets prescribing information.
  2. National Institute for Health and Care Excellence (2022). Epilepsies in children, young people and adults: NICE guideline NG217.
Get our free app Shop faster and track your orders 4.0 · 598 reviews Install